Search

everythinglearnresearchcommunity

for

Search:↓

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Possible link between androgens and COVID-19 severity; more research needed.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

The conclusion is that adult males with muscle weakness and hormonal imbalances should be tested for Kennedy's disease.

Androgens may worsen COVID-19 severity in men.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Mutations in the androgen receptor gene cause different levels of androgen insensitivity, making it hard to create simple tests for the condition.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Finasteride safely lowers DHT levels without affecting testosterone.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Androgens significantly affect female hair loss, and hormonal treatments may help.

G allele of AR Stul polymorphism linked to higher hair loss risk, especially in white people.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Acne is an important sign of androgen excess disorders in women.

A woman developed male traits from accidental contact with her husband's testosterone gel.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.